North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market to register a CAGR of 29.5% during the forecast period (2018 - 2024) - KBV Research

According to a new report North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, published by KBV research, the North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market would witness market growth of 29.5% CAGR during the forecast period (2018 – 2024).

The USA Market held the largest share in the North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2017. The Mexico market is expected to witness a significant CAGR during the forecast period (2018 – 2024).

The Trabecular Meshwork segment contributed the larger revenue share to the North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by target in 2017, and would continue to be a dominant market till 2024 and is expected to grow at a CAGR of 28.9% during the forecast period. However, Suprachoroidal Space segment is expected to grow at CAGR of 30.2% over the forecast period.

Eye Hospitals among the End Users lead the market in 2017 and would continue to dominate the North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by 2024; thereby, growing at a CAGR of 29% during (2018-2024). Additionally, other end user is growing at significant pace contributed by the increased usage of MIGS devices at Outpatient Surgical Centers.

Full Report: https://www.kbvresearch.com/north-america-minimally-invasive-glaucoma-surgery-migs-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.

North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation

By Surgery

• Glaucoma in Conjunction with Cataract
• Stand Alone Glaucoma 

By Target

• Suprachoroidal Space
• Trabecular Meshwork
• Others

By Product

• MIGS Stents
• MIGS Shunts
• Other

By End User

• Eye Hospitals
• Ophthalmology Clinics
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Companies Profiled

• Ellex Medical Lasers Ltd
• Allergan Plc
• Santen Pharmaceutical Co., Ltd.
• Glaukos Corporation
• Alcon Inc. (Novartis)
• Lumenis
• Ivantis, Inc.
• iSTAR Medical
• InnFocus Inc.
• SOLX, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage 
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market